Xelpros FDA Approval History
FDA Approved: Yes (First approved September 12, 2018)
Brand name: Xelpros
Generic name: latanoprost
Dosage form: Ophthalmic Emulsion
Company: Sun Pharmaceutical Industries Inc.
Treatment for: Glaucoma, Open Angle, Intraocular Hypertension
Xelpros (latanoprost) is a prostaglandin F2α analog indicated for reduction of elevated intraocular pressure in patients with open-angle glaucoma, or ocular hypertension.
Xelpros is the first and only form of latanoprost that is not formulated with benzalkonium chloride (BAK), a preservative commonly used in topical ocular preparations.
Development timeline for Xelpros
| Date | Article |
|---|---|
| Sep 14, 2018 | Approval FDA Approves Xelpros (latanoprost ophthalmic emulsion) to Treat Open-angle Glaucoma or Ocular Hypertension |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
